…Introduction Nintedanib slows progression of systemic sclerosis-associated interstitial lung disease (SSc-ILD), but its tolerability is a potential concern.Material and Metho…
SSc-ILD
This disease is selected. Its supporting articles are shown below.
Articles mentioning SSc-ILD
55 articles · page 5 of 5…Introduction Interstitial lung disease (ILD) in systemic sclerosis (SSc) is the leading cause of morbidity a…
…isease (ILD) is the leading cause of mortality in patients with systemic sclerosis (SSc). Early recognition of progression is crucial to enable timely t…
…rials.gov and ClinicalTrialsRegister.eu using ‘scleroderma’ OR ‘systemic sclerosis’ AND ‘CAR-T,’ and screened references from published studies; i…
…l lung disease (ILD) and potential benefits on skin fibrosis in systemic sclerosis (SSc). This study aims to evaluate the safety and effectiveness of TC…
…Background Nintedanib slows progression of systemic sclerosis-associated interstitial lung disease (SSc-ILD), but its tolerability is a potential concern.Methods This multi…